Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Deng L.,,STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors,2014,Immunity,617,10.1016/j.immuni.2014.10.019,United States,Article,Chicago,1,Journal,2-s2.0-84912128872
Vadrevu S.K.,,Complement c5a receptor facilitates cancer metastasis by altering t-cell responses in the metastatic niche,2014,Cancer Research,79,10.1158/0008-5472.CAN-14-0157,United States,Article,Lubbock,1,Journal,2-s2.0-84904015491
Gagliani N.,,The fire within: Microbes inflame tumors,2014,Cell,68,10.1016/j.cell.2014.03.006,United States,Review,New Haven,1,Journal,2-s2.0-84900308871
Lam A.R.,,RAE1 ligands for the NKG2D receptor are regulated by STING-dependent DNA sensor pathways in lymphoma,2014,Cancer Research,70,10.1158/0008-5472.CAN-13-1703,Singapore;Singapore,Article,Singapore City;Singapore City,1,Journal,2-s2.0-84899506551
Spranger S.,,"Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8<sup>+</sup> T cells directly within the tumor microenvironment",2014,Journal for ImmunoTherapy of Cancer,295,10.1186/2051-1426-2-3,United States,Article,Chicago,1,Journal,2-s2.0-84977161108
Yang X.,,Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses,2014,Cancer Cell,148,10.1016/j.ccr.2013.12.004,United States;China,Article,Chicago;Beijing,1,Journal,2-s2.0-84892416698
Spaapen R.M.,,Therapeutic activity of high-dose intratumoral IFN-β requires direct effect on the tumor vasculature,2014,Journal of Immunology,45,10.4049/jimmunol.1401109,United States,Article,Chicago,1,Journal,2-s2.0-84907495019
Fisher J.,,γδ T cells for cancer immunotherapy: A systematic review of clinical trials,2014,OncoImmunology,103,10.4161/onci.27572,United Kingdom,Review,London,1,Journal,2-s2.0-84899048579
Marcus A.,,Recognition of tumors by the innate immune system and natural killer cells,2014,Advances in Immunology,171,10.1016/B978-0-12-800267-4.00003-1,United States,Chapter,Berkeley,0,Book Series,2-s2.0-84893352557
Drake C.,,"Breathing new life into immunotherapy: Review of melanoma, lung and kidney cancer",2014,Nature Reviews Clinical Oncology,262,10.1038/nrclinonc.2013.208,United States,Review,Baltimore,0,Journal,2-s2.0-84890980389
Diefenbach A.,,"Development, differentiation, and diversity of innate lymphoid cells",2014,Immunity,329,10.1016/j.immuni.2014.09.005,Germany,Review,Mainz,1,Journal,2-s2.0-84907968021
Woo S.,,STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors,2014,Immunity,552,10.1016/j.immuni.2014.10.017,United States,Article,Chicago,1,Journal,2-s2.0-84912120595
Luoma A.,,Crystal Structure of Vδ1T Cell Receptor in Complex with CD1d-Sulfatide Shows MHC-like Recognition of a Self-Lipid by Human γδ T Cells,2013,Immunity,122,10.1016/j.immuni.2013.11.001,United States,Article,Chicago,1,Journal,2-s2.0-84890207005
Van Rooij N.,,Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma,2013,Journal of Clinical Oncology,524,10.1200/JCO.2012.47.7521,Netherlands,Article,Amsterdam,0,Journal,2-s2.0-84872841412
Gajewski T.,,Innate and adaptive immune cells in the tumor microenvironment,2013,Nature Immunology,1404,10.1038/ni.2703,United States,Review,Chicago,0,Journal,2-s2.0-84886698315
Ajona D.,,Investigation of complement activation product C4d as a diagnostic and prognostic biomarker for lung cancer,2013,Journal of the National Cancer Institute,77,10.1093/jnci/djt205,Spain,Article,Pamplona,1,Journal,2-s2.0-84886897241
Spranger S.,,"Up-regulation of PD-L1, IDO, and T<inf>regs</inf> in the melanoma tumor microenvironment is driven by CD8<sup>+</sup> T cells",2013,Science Translational Medicine,896,10.1126/scitranslmed.3006504,United States,Review,Chicago,0,Journal,2-s2.0-84883863501
Dudek A.,,Inducers of immunogenic cancer cell death,2013,Cytokine and Growth Factor Reviews,108,10.1016/j.cytogfr.2013.01.005,Belgium,Review,Leuven,0,Journal,2-s2.0-84883785740
Atarashi K.,,T<inf>reg</inf> induction by a rationally selected mixture of Clostridia strains from the human microbiota,2013,Nature,1323,10.1038/nature12331,Japan;Japan;Japan,Article,Tokyo;Wako;Kawaguchi,0,Journal,2-s2.0-84881477044
Gehrmann U.,,Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomes,2013,Cancer Research,68,10.1158/0008-5472.CAN-12-3918,Sweden,Article,Stockholm,1,Journal,2-s2.0-84880049306
Crome S.,,Natural killer cells regulate diverse T cell responses,2013,Trends in Immunology,90,10.1016/j.it.2013.03.002,Canada,Review,Toronto,0,Journal,2-s2.0-84880799474
Yoshimoto S.,,Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome,2013,Nature,926,10.1038/nature12347,Japan;Japan,Article,Tokyo;Kawaguchi,0,Journal,2-s2.0-84879888338
Ascierto M.L.,,Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients,2013,Journal of Translational Medicine,52,10.1186/1479-5876-11-145,Italy;United States,Article,Genoa;Bethesda,1,Journal,2-s2.0-84878817192
Hu B.,,Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation,2013,Proceedings of the National Academy of Sciences of the United States of America,155,10.1073/pnas.1307575110,United States,Article,New Haven,1,Journal,2-s2.0-84878971321
Robbins P.,,Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells,2013,Nature Medicine,638,10.1038/nm.3161,United States,Article,Bethesda,0,Journal,2-s2.0-84880276438
Kirchberger S.,,Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model,2013,Journal of Experimental Medicine,328,10.1084/jem.20122308,United Kingdom,Article,Oxford,1,Journal,2-s2.0-84879571464
Cheng M.,,NK cell-based immunotherapy for malignant diseases,2013,Cellular and Molecular Immunology,339,10.1038/cmi.2013.10,China,Review,Hefei,1,Journal,2-s2.0-84877602763
Ma Y.,,Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells,2013,Immunity,334,10.1016/j.immuni.2013.03.003,France;France;France,Article,Saint-Aubin;Villejuif;Paris,1,Journal,2-s2.0-84876753532
Kvistborg P.,,Human cancer regression antigens,2013,Current Opinion in Immunology,25,10.1016/j.coi.2013.03.005,Netherlands,Review,Amsterdam,0,Journal,2-s2.0-84877085288
Hsieh C.,,The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells,2013,Blood,60,10.1182/blood-2012-06-440214,United States,Article,Cleveland,0,Journal,2-s2.0-84876460778
Demoulin S.,,Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: Insight into the molecular mechanisms,2013,Journal of Leukocyte Biology,76,10.1189/jlb.0812397,Belgium,Review,Liege,1,Journal,2-s2.0-84874537663
Raulet D.,,Regulation of ligands for the NKG2D activating receptor,2013,Annual Review of Immunology,407,10.1146/annurev-immunol-032712-095951,United States,Review,Berkeley,0,Book Series,2-s2.0-84875509728
Frederick D.,,BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma,2013,Clinical Cancer Research,552,10.1158/1078-0432.CCR-12-1630,United States,Article,Boston,1,Journal,2-s2.0-84874872137
Kroemer G.,,Immunogenic cell death in cancer therapy,2013,Annual Review of Immunology,1201,10.1146/annurev-immunol-032712-100008,France;France;France;France;France,Review,Paris;Saint-Aubin;Paris;Paris;Villejuif,0,Book Series,2-s2.0-84875552922
Jiang R.,,IL-22 is related to development of human colon cancer by activation of STAT3,2013,BMC Cancer,106,10.1186/1471-2407-13-59,China;China,Article,Nanjing;Beijing,1,Journal,2-s2.0-84873253765
Fuertes M.,,Type I interferon response and innate immune sensing of cancer,2013,Trends in Immunology,139,10.1016/j.it.2012.10.004,United States,Review,Chicago,0,Journal,2-s2.0-84873111794
Strainic M.,,Absence of signaling into CD4 + cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3 + regulatory T cells,2013,Nature Immunology,182,10.1038/ni.2499,United States,Article,Cleveland,0,Journal,2-s2.0-84872681454
Richter J.,,Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma,2013,Blood,97,10.1182/blood-2012-06-435503,United States,Article,New Haven,1,Journal,2-s2.0-84872481628
Shimizu K.,,"Vaccination with antigen-transfected, NKT cell ligand-loaded, human cells elicits robust in situ immune responses by dendritic cells",2013,Cancer Research,22,10.1158/0008-5472.CAN-12-0759,Japan;Japan,Article,Wako;Wako,1,Journal,2-s2.0-84871969182
Di Carlo E.,,Mechanisms of the antitumor activity of human Vγ9Vδ2 T cells in combination with zoledronic acid in a preclinical model of neuroblastoma,2013,Molecular Therapy,30,10.1038/mt.2013.38,Italy,Conference Paper,Chieti,1,Journal,2-s2.0-84877031179
Viaud S.,,The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide,2013,Science,750,10.1126/science.1240537,France;France,Article,Saint-Aubin;Paris,0,Journal,2-s2.0-84888059687
Iida N.,,Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment,2013,Science,772,10.1126/science.1240527,United States,Article,Frederick,0,Journal,2-s2.0-84888049920
Jung H.,,"RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which controlcell cycle entry",2012,Journal of Experimental Medicine,72,10.1084/jem.20120565,United States,Article,Berkeley,1,Journal,2-s2.0-84871915611
Garg A.,,The emergence of phox-ER stress induced immunogenic apoptosis,2012,OncoImmunology,58,10.4161/onci.19750,Belgium,Article,Leuven,1,Journal,2-s2.0-84866904950
Zhang Q.,,Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature,2012,PLoS ONE,423,10.1371/journal.pone.0050946,China,Article,Chengdu,1,Journal,2-s2.0-84871694284
Krysko D.,,Immunogenic cell death and DAMPs in cancer therapy,2012,Nature Reviews Cancer,671,10.1038/nrc3380,Belgium,Review,Ghent,0,Journal,2-s2.0-84870239310
Ma C.,,Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer,2012,Journal of Immunology,109,10.4049/jimmunol.1201892,United States;China,Article,St. Louis;Linyi,1,Journal,2-s2.0-84868578365
Grivennikov S.I.,,Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth,2012,Nature,656,10.1038/nature11465,United States,Article,San Diego,0,Journal,2-s2.0-84868613705
Joseph R.,,Characterizing the clinical benefit of ipilimumab in patients who progressed on high-dose IL-2,2012,Journal of Immunotherapy,16,10.1097/CJI.0b013e3182742c27,United States,Article,Jacksonville,0,Journal,2-s2.0-84868252005
Labidi-Galy S.,,Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis,2012,OncoImmunology,52,10.4161/onci.18801,France;France;France;France;France,Article,Lyon;Lyon;Villeurbanne;Lyon;Lyon,1,Journal,2-s2.0-84869174655
Corrales L.,,Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression,2012,Journal of Immunology,133,10.4049/jimmunol.1201654,Spain,Article,Pamplona,1,Journal,2-s2.0-84867919350
Huang Y.,,Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy,2012,Proceedings of the National Academy of Sciences of the United States of America,413,10.1073/pnas.1215397109,United States,Article,Boston,1,Journal,2-s2.0-84867902940
Tan K.L.,,Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: A correlative study from the E2496 Intergroup trial,2012,Blood,138,10.1182/blood-2012-04-421057,Canada,Article,Vancouver,0,Journal,2-s2.0-84868116570
Sisirak V.,,Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression,2012,Cancer Research,152,10.1158/0008-5472.CAN-11-3468,France;France;France;France;France,Article,Lyon;Lyon;Villeurbanne;Lyon;Lyon,1,Journal,2-s2.0-84867520423
Gunn L.,,Opposing roles for complement component C5a in tumor progression and the tumor microenvironment,2012,Journal of Immunology,48,10.4049/jimmunol.1200846,United States;United States,Article,Louisville;Louisville,1,Journal,2-s2.0-84866149234
Chiba S.,,Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1,2012,Nature Immunology,356,10.1038/ni.2376,Japan,Article,Sapporo,0,Journal,2-s2.0-84865422909
Liu X.,,Ras activation induces expression of Raet1 family NK receptor ligands,2012,Journal of Immunology,41,10.4049/jimmunol.1200965,Singapore,Article,Singapore City,1,Journal,2-s2.0-84864803198
Venereau E.,,Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release,2012,Journal of Experimental Medicine,376,10.1084/jem.20120189,Italy,Article,Milan,1,Journal,2-s2.0-84866378556
Ganal S.,,Priming of Natural Killer Cells by Nonmucosal Mononuclear Phagocytes Requires Instructive Signals from Commensal Microbiota,2012,Immunity,235,10.1016/j.immuni.2012.05.020,Germany;Germany,Article,Freiburg im Breisgau;Freiburg,1,Journal,2-s2.0-84864322646
Abt M.C.,,Commensal Bacteria Calibrate the Activation Threshold of Innate Antiviral Immunity,2012,Immunity,439,10.1016/j.immuni.2012.04.011,United States,Article,Philadelphia,1,Journal,2-s2.0-84864311450
Medrek C.,,The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients,2012,BMC Cancer,311,10.1186/1471-2407-12-306,Sweden,Article,Lund,1,Journal,2-s2.0-84864828790
Yang G.,,Increased expression of HMGB1 is associated with poor prognosis in human bladder cancer,2012,Journal of Surgical Oncology,60,10.1002/jso.23040,China,Article,Shanghai,0,Journal,2-s2.0-84862797755
Jube S.,,Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma,2012,Cancer Research,145,10.1158/0008-5472.CAN-11-3481,United States,Article,Honolulu,1,Journal,2-s2.0-84863599924
Ji R.R.,,An immune-active tumor microenvironment favors clinical response to ipilimumab,2012,"Cancer Immunology, Immunotherapy",446,10.1007/s00262-011-1172-6,United States,Article,New York,0,Journal,2-s2.0-84862769116
Topalian S.,,"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer",2012,New England Journal of Medicine,7193,10.1056/NEJMoa1200690,United States,Article,Baltimore,0,Journal,2-s2.0-84862859820
Zou W.,,LIGHT delivery to tumors by mesenchymal stem cells mobilizes an effective antitumor immune response,2012,Cancer Research,25,10.1158/0008-5472.CAN-11-4216,China,Article,Hangzhou,1,Journal,2-s2.0-84862523773
Hooper L.,,Interactions between the microbiota and the immune system,2012,Science,1967,10.1126/science.1223490,United States,Review,Dallas,0,Journal,2-s2.0-84861980130
Sacks S.H.,,The role of complement in the early immune response to transplantation,2012,Nature Reviews Immunology,129,10.1038/nri3225,United Kingdom,Review,London,0,Journal,2-s2.0-84861538912
Miyamoto S.,,Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma,2012,Cancer Research,100,10.1158/0008-5472.CAN-11-3185,Japan,Article,Fukuoka,1,Journal,2-s2.0-84861112821
Stagg J.,,CD73-Deficient mice are resistant to carcinogenesis,2012,Cancer Research,130,10.1158/0008-5472.CAN-12-0420,Australia;Canada,Article,Melbourne;,1,Journal,2-s2.0-84860382842
Beavis P.,,CD73: A potent suppressor of antitumor immune responses,2012,Trends in Immunology,190,10.1016/j.it.2012.02.009,Australia,Review,Melbourne,0,Journal,2-s2.0-84860388676
Ahrens S.,,"F-Actin Is an Evolutionarily Conserved Damage-Associated Molecular Pattern Recognized by DNGR-1, a Receptor for Dead Cells",2012,Immunity,233,10.1016/j.immuni.2012.03.008,United Kingdom,Article,London,1,Journal,2-s2.0-84859957011
Liu R.,,Densely granulated murine NK cells eradicate large solid tumors,2012,Cancer Research,37,10.1158/0008-5472.CAN-11-3208,United States,Article,Chicago,1,Journal,2-s2.0-84860150685
Garg A.,,A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death,2012,EMBO Journal,366,10.1038/emboj.2011.497,Belgium,Article,Leuven,0,Journal,2-s2.0-84857997683
Erdag G.,,Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma,2012,Cancer Research,272,10.1158/0008-5472.CAN-11-3218,United States;United States,Article,Charlottesville;Baltimore,1,Journal,2-s2.0-84857746620
González-Navajas J.,,Immunomodulatory functions of type i interferons,2012,Nature Reviews Immunology,571,10.1038/nri3133,Spain;United States;Spain,Review,Madrid;San Diego;Alicante,0,Journal,2-s2.0-84856226112
Lord C.,,The DNA damage response and cancer therapy,2012,Nature,864,10.1038/nature10760,United Kingdom,Review,London,0,Journal,2-s2.0-84856019858
Martins I.,,Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death,2012,Autophagy,58,10.4161/auto.19009,France;France;France,Short Survey,Saint-Aubin;Villejuif;Paris,1,Journal,2-s2.0-84859207675
Yang H.,,Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1),2012,Molecular Medicine,298,10.2119/molmed.2011.00389,United States,Article,Manhasset,1,Journal,2-s2.0-84860862890
Michaud M.,,Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice,2011,Science,717,10.1126/science.1208347,France;France;France,Article,Villejuif;Le Kremlin-Bicetre;Paris,0,Journal,2-s2.0-83755181759
Kolev M.,,Complement in cancer and cancer immunotherapy,2011,Archivum Immunologiae et Therapiae Experimentalis,48,10.1007/s00005-011-0146-x,United Kingdom,Review,Cardiff,0,Journal,2-s2.0-82355191791
Caricilli A.M.,,Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice,2011,PLoS Biology,201,10.1371/journal.pbio.1001212,Brazil,Article,Campinas,1,Journal,2-s2.0-84855174006
Hamid O.,,A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma,2011,Journal of Translational Medicine,350,10.1186/1479-5876-9-204,United States,Article,Santa Monica,1,Journal,2-s2.0-82155168544
Diamond M.,,Type I interferon is selectively required by dendritic cells for immune rejection of tumors,2011,Journal of Experimental Medicine,502,10.1084/jem.20101158,United States,Article,St. Louis,1,Journal,2-s2.0-80355147292
Fuertes M.,,Host type I IFN signals are required for antitumor CD8<sup>+</sup> T cell responses through CD8α<sup>+</sup> dendritic cells,2011,Journal of Experimental Medicine,552,10.1084/jem.20101159,United States,Article,Chicago,1,Journal,2-s2.0-80355136945
Balachandran V.,,Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido,2011,Nature Medicine,350,10.1038/nm.2438,United States,Article,New York,0,Journal,2-s2.0-80052493233
Mattarollo S.,,Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors,2011,Cancer Research,199,10.1158/0008-5472.CAN-11-0753,Australia;Australia,Article,Melbourne;Brisbane,1,Journal,2-s2.0-79960426821
Qian B.Z.,,CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis,2011,Nature,1284,10.1038/nature10138,United States,Article,New York,0,Journal,2-s2.0-79960411324
Marcu-Malina V.,,Redirecting αβT cells against cancer cells by transfer of a broadly tumor-reactive γδT-cell receptor,2011,Blood,49,10.1182/blood-2010-12-325993,Netherlands,Article,Utrecht,0,Journal,2-s2.0-79960147928
Elinav E.,,NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis,2011,Cell,1171,10.1016/j.cell.2011.04.022,United States,Article,New Haven,1,Journal,2-s2.0-79957576718
Mahmoud S.M.A.,,Tumor-infiltrating CD8<sup>+</sup> lymphocytes predict clinical outcome in breast cancer,2011,Journal of Clinical Oncology,767,10.1200/JCO.2010.30.5037,United Kingdom;United Kingdom;Egypt,Article,Nottingham;Nottingham;Mansoura,0,Journal,2-s2.0-79956329617
Ardolino M.,,DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: Relevance for NK-T cell interaction,2011,Blood,80,10.1182/blood-2010-08-300954,Italy,Article,Rome,0,Journal,2-s2.0-79955974536
Barbalat R.,,Nucleic acid recognition by the innate immune system,2011,Annual Review of Immunology,371,10.1146/annurev-immunol-031210-101340,United States,Article,Berkeley,0,Book Series,2-s2.0-79953062340
Mortensen S.,,Local release of ATP into the arterial inflow and venous drainage of human skeletal muscle: Insight from ATP determination with the intravascular microdialysis technique,2011,Journal of Physiology,72,10.1113/jphysiol.2010.203034,Denmark,Article,Copenhagen,0,Journal,2-s2.0-79953156756
Watkins S.K.,,FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer,2011,Journal of Clinical Investigation,108,10.1172/JCI44325,Japan,Article,Tokyo,0,Journal,2-s2.0-79953323468
Burnette B.,,The efficacy of radiotherapy relies upon induction of type I interferon-dependent innate and adaptive immunity,2011,Cancer Research,400,10.1158/0008-5472.CAN-10-2820,United States,Article,Chicago,1,Journal,2-s2.0-79953295544
Beatty G.L.,,CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans,2011,Science,909,10.1126/science.1198443,United States;United States,Article,Philadelphia;Philadelphia,0,Journal,2-s2.0-79953154967
Mannik L.,,Engagement of glycosylphosphatidylinositol-anchored proteins results in enhanced mouse and human invariant natural killer T cell responses,2011,Immunology,8,10.1111/j.1365-2567.2010.03369.x,Canada,Article,London,0,Journal,2-s2.0-79251616955
Kobayashi H.,,A new indicator of favorable prognosis in locally advanced renal cell carcinomas: γδ T-cells in peripheral blood,2011,Anticancer Research,11,,Japan,Article,Tokyo,0,Journal,2-s2.0-79956083387
Laursen L.,,E. coli crisis opens door for Alexion drug trial.,2011,Nature biotechnology,6,10.1038/nbt0811-671,,Note,,0,Journal,2-s2.0-84856400432
Rathinam V.,,Cytosolic surveillance and antiviral immunity,2011,Current Opinion in Virology,50,10.1016/j.coviro.2011.11.004,United States,Review,Worcester,0,Journal,2-s2.0-82955178645
Van Kaer L.,,Invariant natural killer T cells: Bridging innate and adaptive immunity,2011,Cell and Tissue Research,98,10.1007/s00441-010-1023-3,United States,Review,Nashville,0,Journal,2-s2.0-79051471632
Pawaria S.,,CD91-dependent programming of T-helper cell responses following heat shock protein immunization,2011,Nature Communications,106,10.1038/ncomms1524,United States,Article,Pittsburgh,1,Journal,2-s2.0-84855712718
Delahaye N.F.,,Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors,2011,Nature Medicine,205,10.1038/nm.2366,France;France;France,Article,Villejuif;Paris;Villejuif,0,Journal,2-s2.0-79958118266
Lee Y.,,Has the microbiota played a critical role in the evolution of the adaptive immune system?,2010,Science,644,10.1126/science.1195568,United States,Review,Pasadena,0,Journal,2-s2.0-78650647326
Rakhra K.,,CD4+ T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene Inactivation,2010,Cancer Cell,48,10.1016/j.ccr.2010.12.001,,Erratum,,1,Journal,2-s2.0-78649993460
Davis A.,,"C1 inhibitor, a multi-functional serine protease inhibitor",2010,Thrombosis and Haemostasis,140,10.1160/TH10-01-0073,United States,Conference Paper,Boston,0,Journal,2-s2.0-78149481863
Pio R.,,Complement factor H is elevated in bronchoalveolar lavage fluid and sputum from patients with lung cancer,2010,Cancer Epidemiology Biomarkers and Prevention,13,10.1158/1055-9965.EPI-10-0467,Spain;Spain,Article,Pamplona;Pamplona,1,Journal,2-s2.0-77958034853
Ricklin D.,,Complement: A key system for immune surveillance and homeostasis,2010,Nature Immunology,1909,10.1038/ni.1923,United States,Review,Philadelphia,0,Journal,2-s2.0-77955883153
Gajewski T.,,Gene signature in melanoma associated with clinical activity a potential clue to unlock cancer immunotherapy,2010,Cancer Journal,195,10.1097/PPO.0b013e3181eacbd8,United States,Review,Chicago,0,Journal,2-s2.0-77958012775
Solinas G.,,"Tumor-conditioned macrophages secrete migration-stimulating factor: A new marker for M2-polarization, influencing tumor cell motility",2010,Journal of Immunology,231,10.4049/jimmunol.1000413,Italy,Article,Rozzano,1,Journal,2-s2.0-77956212940
Wang Y.,,Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses,2010,Cancer Research,242,10.1158/0008-5472.CAN-10-0269,China,Article,Xi'an,1,Journal,2-s2.0-77953752609
Crozat K.,,The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8α<sup>+</sup> dendritic cells,2010,Journal of Experimental Medicine,426,10.1084/jem.20100223,France;France;France,Article,Marseille;Paris;Paris,0,Journal,2-s2.0-77953506509
Poulin L.F.,,Characterization of human DNGR-1<sup>+</sup> BDCA3<sup>+</sup> leukocytes as putative equivalents of mouse CD8α<sup>+</sup> dendritic cells,2010,Journal of Experimental Medicine,494,10.1084/jem.20092618,United Kingdom,Article,London,0,Journal,2-s2.0-77953484184
Nückel H.,,The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia,2010,Leukemia,71,10.1038/leu.2010.74,Germany,Article,Essen,1,Journal,2-s2.0-77954613267
Peng R.,,Expression of calreticulin is associated with infiltration of T-cells in stage III B colon cancer,2010,World Journal of Gastroenterology,60,10.3748/wjg.v16.i19.2428,China,Article,Guangzhou,1,Journal,2-s2.0-77953219151
Mishra R.,,NK cells and γδ T cells mediate resistance to polyomavirus-induced tumors,2010,PLoS Pathogens,14,10.1371/journal.ppat.1000924,United States,Article,Worcester,1,Journal,2-s2.0-77954041995
Vijay-Kumar M.,,Metabolie syndrome and altered gut microbiota in mice lacking toll-like receptor 5,2010,Science,1281,10.1126/science.1179721,United States,Article,Atlanta,0,Journal,2-s2.0-77950250064
U'Ren L.,,Type I interferons inhibit the generation of tumor-associated macrophages,2010,"Cancer Immunology, Immunotherapy",17,10.1007/s00262-009-0776-6,United States,Article,Fort Collins,0,Journal,2-s2.0-77449089079
Kessenbrock K.,,Matrix Metalloproteinases: Regulators of the Tumor Microenvironment,2010,Cell,2717,10.1016/j.cell.2010.03.015,United States,Review,San Francisco,1,Journal,2-s2.0-77950931419
Grivennikov S.,,"Immunity, Inflammation, and Cancer",2010,Cell,5504,10.1016/j.cell.2010.01.025,United States,Review,San Diego,1,Journal,2-s2.0-77950346282
Zabuawala T.,,An Ets2-driven transcriptional program in tumor-associated macrophages promotes tumor metastasis,2010,Cancer Research,86,10.1158/0008-5472.CAN-09-1474,United States;United States,Article,Columbus;Columbus,1,Journal,2-s2.0-76749096776
Wang Y.,,Promoting immune responses by LIGHT in the face of abundant regulatory T cell inhibition,2010,Journal of Immunology,10,10.4049/jimmunol.0901582,United States,Article,Chicago,1,Journal,2-s2.0-77949324525
Mantovani A.,,The chemokine system in cancer biology and therapy,2010,Cytokine and Growth Factor Reviews,252,10.1016/j.cytogfr.2009.11.007,Italy;Italy,Article,Milan;Rozzano,0,Journal,2-s2.0-77549083248
Wemeau M.,,Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia,2010,Cell Death and Disease,79,10.1038/cddis.2010.82,France;France;France;France,Article,Villejuif;Saint-Aubin;Villejuif;Villejuif,1,Journal,2-s2.0-79952397249
Garg A.D.,,"Immunogenic cell death, DAMPs and anticancer therapeutics: An emerging amalgamation",2010,Biochimica et Biophysica Acta - Reviews on Cancer,277,10.1016/j.bbcan.2009.08.003,Belgium,Review,3000 Leuven,0,Journal,2-s2.0-75349083568
Barber A.,,Chimeric NKG2D expressing T cells eliminate immunosuppression and activate immunity within the ovarian tumor microenvironment,2009,Journal of Immunology,59,10.4049/jimmunol.0902000,United States,Article,Hanover,1,Journal,2-s2.0-73349123470
Do J.,,IL-15 produced and trans-presented by DCs underlies homeostatic competition between CD8 and γδ T cells in vivo,2009,Blood,18,10.1182/blood-2008-12-192997,United States,Article,Cleveland,0,Journal,2-s2.0-67650638845
Swann J.B.,,Type I natural killer T cells suppress tumors caused by p53 loss in mice,2009,Blood,74,10.1182/blood-2009-01-198564,Australia;Australia,Article,Melbourne;Parkville,0,Journal,2-s2.0-67650609686
Martins I.,,Chemotherapy induces ATP release from tumor cells,2009,Cell Cycle,161,10.4161/cc.8.22.10026,France;France;France,Article,Saint-Aubin;Villejuif;Paris,1,Journal,2-s2.0-70449781226
Ivanov I.I.,,Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria,2009,Cell,2522,10.1016/j.cell.2009.09.033,United States,Article,New York,1,Journal,2-s2.0-70350343544
Devilder M.,,Early triggering of exclusive IFN-γ responses of human Vγ9Vδ2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells,2009,Journal of Immunology,55,10.4049/jimmunol.0901571,France,Article,Nantes,1,Journal,2-s2.0-70349323173
Elliott M.R.,,Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance,2009,Nature,836,10.1038/nature08296,United States,Article,Charlottesville,0,Journal,2-s2.0-70249090374
Gancz D.,,Cancer resistance to complement-dependent cytotoxicity (CDC): Problem-oriented research and development,2009,Molecular Immunology,61,10.1016/j.molimm.2009.05.009,Israel,Review,Ramal Aviv,0,Journal,2-s2.0-68049135726
DeNardo D.G.,,CD4<sup>+</sup> T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages,2009,Cancer Cell,783,10.1016/j.ccr.2009.06.018,United States,Article,San Francisco,1,Journal,2-s2.0-67651160649
Raulet D.,,Oncogenic stress sensed by the immune system: Role of natural killer cell receptors,2009,Nature Reviews Immunology,241,10.1038/nri2604,United States,Review,Berkeley,0,Journal,2-s2.0-68849105814
Duluc D.,,Interferon-γ reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages,2009,International Journal of Cancer,175,10.1002/ijc.24401,France;France,Article,Angers;Angers,1,Journal,2-s2.0-67449088117
Martinet L.,,A regulatory cross-talk between Vγ9Vδ2 T lymphocytes and mesenchymal stem cells,2009,European Journal of Immunology,72,10.1002/eji.200838812,France;France,Article,Toulouse;Toulouse,0,Journal,2-s2.0-64049097932
Kuang D.,,Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1,2009,Journal of Experimental Medicine,474,10.1084/jem.20082173,China,Article,Guangzhou,1,Journal,2-s2.0-67449110979
Torroella-Kouri M.,,Identification of a subpopulation of macrophages in mammary tumor-bearing mice that are neither M1 nor M2 and are less differentiated,2009,Cancer Research,83,10.1158/0008-5472.CAN-08-3427,United States;United States,Article,Miami;Miami,1,Journal,2-s2.0-66349099293
Markiewski M.,,Is complement good or bad for cancer patients? A new perspective on an old dilemma,2009,Trends in Immunology,103,10.1016/j.it.2009.04.002,United States,Review,Philadelphia,0,Journal,2-s2.0-66549124166
Martinet L.,,Pitfalls on the roadmap to γδ T cell-based cancer immunotherapies,2009,Immunology Letters,33,10.1016/j.imlet.2009.03.011,France;France,Review,Toulouse;Toulouse,0,Journal,2-s2.0-67349178132
Lakshmikanth T.,,NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo,2009,Journal of Clinical Investigation,222,10.1172/JCI36022,Italy;Sweden,Article,Catanzaro;Stockholm,1,Journal,2-s2.0-66449134616
Green D.R.,,Immunogenic and tolerogenic cell death,2009,Nature Reviews Immunology,630,10.1038/nri2545,United States,Review,"Memphis TN,",0,Journal,2-s2.0-67349124914
Sancho D.,,Identification of a dendritic cell receptor that couples sensing of necrosis to immunity,2009,Nature,452,10.1038/nature07750,United Kingdom,Article,London,0,Journal,2-s2.0-67249158956
Soriani A.,,ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype,2009,Blood,268,10.1182/blood-2008-08-173914,Italy;Italy,Article,Rome;Rome,0,Journal,2-s2.0-65349131915
Harlin H.,,Chemokine expression in melanoma metastases associated with CD8 <sup>+</sup> T-CeII recruitment,2009,Cancer Research,517,10.1158/0008-5472.CAN-08-2281,United States,Article,Chicago,1,Journal,2-s2.0-66149156276
Reich C.,,The content of DNA and RNA in microparticles released by Jurkat and HL-60 cells undergoing in vitro apoptosis,2009,Experimental Cell Research,84,10.1016/j.yexcr.2008.12.014,United States;United States,Article,Durham;Durham,0,Journal,2-s2.0-59849112828
Panaretakis T.,,Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death,2009,EMBO Journal,421,10.1038/emboj.2009.1,France;France;France,Article,Saint-Aubin;Villejuif;Paris,0,Journal,2-s2.0-62049085194
Kunzmann V.,,Inhibition of phosphoantigen-mediated γδ T-cell proliferation by CD4<sup>+</sup> CD25<sup>+</sup> FoxP3<sup>+</sup> regulatory T cells,2009,Immunology,65,10.1111/j.1365-2567.2008.02894.x,Germany,Article,Wurzburg,1,Journal,2-s2.0-58149277219
Ghiringhelli F.,,Activation of the NLRP3 inflammasome in dendritic cells induces IL-1Β-dependent adaptive immunity against tumors,2009,Nature Medicine,1014,10.1038/nm.2028,France;France,Article,Villejuif;Paris,0,Journal,2-s2.0-70350569295
Iguchi-Manaka A.,,Accelerated tumor growth in mice deficient in DNAM-1 receptor,2008,Journal of Experimental Medicine,161,10.1084/jem.20081611,Japan,Article,Tsukuba,1,Journal,2-s2.0-59649091694
Terabe M.,,Chapter 8 The Role of NKT Cells in Tumor Immunity,2008,Advances in Cancer Research,213,10.1016/S0065-230X(08)00408-9,United States,Review,Bethesda,0,Book Series,2-s2.0-56849090964
Ryder M.,,Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer,2008,Endocrine-Related Cancer,230,10.1677/ERC-08-0036,United States,Article,New York,0,Journal,2-s2.0-56649101166
Grauer O.,,TLR ligands in the local treatment of established intracerebral murine gliomas,2008,Journal of Immunology,91,10.4049/jimmunol.181.10.6720,Germany;Netherlands,Article,Regensburg;Nijmegen,1,Journal,2-s2.0-58149177780
Hildner K.,,Batf3 deficiency reveals a critical role for CD8α<sup>+</sup> dendritic cells in cytotoxic T cell immunity,2008,Science,1010,10.1126/science.1164206,United States,Article,St. Louis,0,Journal,2-s2.0-56449097442
Berzofsky J.,,A novel immunoregulatory axis of NKT cell subsets regulating tumor immunity,2008,"Cancer Immunology, Immunotherapy",46,10.1007/s00262-008-0495-4,United States,Conference Paper,Bethesda,0,Journal,2-s2.0-50649087259
Ivanov I.I.,,Specific Microbiota Direct the Differentiation of IL-17-Producing T-Helper Cells in the Mucosa of the Small Intestine,2008,Cell Host and Microbe,1023,10.1016/j.chom.2008.09.009,United States,Article,New York,1,Journal,2-s2.0-53349173070
De Palma M.,,Tumor-Targeted Interferon-α Delivery by Tie2-Expressing Monocytes Inhibits Tumor Growth and Metastasis,2008,Cancer Cell,183,10.1016/j.ccr.2008.09.004,Italy;Italy,Article,Milan;Milan,1,Journal,2-s2.0-52949148222
Waldhauer I.,,NK cells and cancer immunosurveillance,2008,Oncogene,385,10.1038/onc.2008.267,Germany,Review,Tubingen,1,Journal,2-s2.0-53549114206
Fourcade J.,,Immunization with analog peptide in combination with CpG and montanide expands tumor antigen-specific CD8+ T cells in melanoma patients,2008,Journal of Immunotherapy,75,10.1097/CJI.0b013e318183af0b,United States,Article,Pittsburgh,0,Journal,2-s2.0-59849116262
Markiewski M.M.,,Modulation of the antitumor immune response by complement,2008,Nature Immunology,428,10.1038/ni.1655,United States,Article,Philadelphia,0,Journal,2-s2.0-54549109936
Kawai O.,,Predominant infiltration of macrophages and CD8<sup>+</sup> T cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer,2008,Cancer,258,10.1002/cncr.23712,Japan;Japan,Article,Tokyo;Kashiwa,0,Journal,2-s2.0-53149083361
Moreno M.,,IFN-γ-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses,2008,Journal of Immunology,40,10.4049/jimmunol.181.4.2446,Netherlands,Article,Amsterdam,1,Journal,2-s2.0-53149134714
Mantovani A.,,Cancer-related inflammation,2008,Nature,6124,10.1038/nature07205,Italy;Italy,Review,Milan;Rozzano,0,Journal,2-s2.0-47949096781
Sancho D.,,"Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin",2008,Journal of Clinical Investigation,340,10.1172/JCI34584,United Kingdom,Article,London,0,Journal,2-s2.0-45749112103
Saitoh A.,,Anti-tumor cytotoxicity of γδ T cells expanded from peripheral blood cells of patients with myeloma and lymphoma,2008,Medical Oncology,29,10.1007/s12032-007-9004-4,Japan;Japan,Article,Niigata;Niigata,0,Journal,2-s2.0-48049116706
Tokuyama H.,,Vγ9Vδ2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs - Rituximab and trastuzumab,2008,International Journal of Cancer,80,10.1002/ijc.23365,Australia;Japan,Article,Brisbane;Tokyo,1,Journal,2-s2.0-42549138403
Matsuda J.,,"CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system",2008,Current Opinion in Immunology,282,10.1016/j.coi.2008.03.018,United States,Review,Denver,0,Journal,2-s2.0-45449103839
Mazmanian S.,,A microbial symbiosis factor prevents intestinal inflammatory disease,2008,Nature,1392,10.1038/nature07008,United States,Article,Pasadena,0,Journal,2-s2.0-44449106055
Ugurel S.,,Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy,2008,"Cancer Immunology, Immunotherapy",62,10.1007/s00262-007-0407-z,Germany,Article,Wurzburg,0,Journal,2-s2.0-41549123803
Guerra N.,,NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy,2008,Immunity,486,10.1016/j.immuni.2008.02.016,United States,Article,Berkeley,1,Journal,2-s2.0-41549163195
Coudert J.D.,,Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways,2008,Blood,107,10.1182/blood-2007-07-100057,Switzerland,Article,Lausanne,0,Journal,2-s2.0-43549123826
Kono H.,,How dying cells alert the immune system to danger,2008,Nature Reviews Immunology,1110,10.1038/nri2215,United States,Review,Worcester,0,Journal,2-s2.0-41149118513
Liu C.,,"Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice",2008,Journal of Clinical Investigation,216,10.1172/JCI33583,United States,Article,Houston,1,Journal,2-s2.0-40549143697
Kondo M.,,Zoledronate facilitates large-scale ex vivo expansion of functional γδ T cells from cancer patients for use in adoptive immunotherapy,2008,Cytotherapy,100,10.1080/14653240802419328,Japan,Article,Kanagawa,0,Journal,2-s2.0-57949103408
Adams S.,,Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant,2008,Journal of Immunology,201,10.4049/jimmunol.181.1.776,United States,Article,New York,1,Journal,2-s2.0-47949129948
Chen W.,,"The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation",2008,Journal of Immunology,307,10.4049/jimmunol.181.8.5396,United States,Article,Minneapolis,1,Journal,2-s2.0-54049151564
Tesniere A.,,Molecular characteristics of immunogenic cancer cell death,2008,Cell Death and Differentiation,280,10.1038/sj.cdd.4402269,France;France;France,Review,Saint-Aubin;Villejuif;Paris,1,Journal,2-s2.0-37349051718
Buckanovich R.J.,,Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy,2008,Nature Medicine,322,10.1038/nm1699,United States;United States,Article,Ann Arbor;Philadelphia,0,Journal,2-s2.0-38049000452
Crow M.,,Type I interferon in systemic lupus erythematosus,2007,Current Topics in Microbiology and Immunology,87,10.1007/978-3-540-71329-6-17,United States,Review,New York,0,Book Series,2-s2.0-38449088518
Obeid M.,,Ecto-calreticulin in immunogenic chemotherapy,2007,Immunological Reviews,142,10.1111/j.1600-065X.2007.00567.x,France;France;France,Review,Saint-Aubin;Villejuif;Paris,0,Journal,2-s2.0-35748933181
Ambrosino E.,,Cross-regulation between type I and type II NKT cells in regulating tumor immunity: A new immunoregulatory axis,2007,Journal of Immunology,148,10.4049/jimmunol.179.8.5126,United States,Article,Bethesda,1,Journal,2-s2.0-36049022618
Burjanadzé M.,,In vitro expansion of gamma delta T cells with anti-myeloma cell activity by Phosphostim and IL-2 in patients with multiple myeloma,2007,British Journal of Haematology,51,10.1111/j.1365-2141.2007.06754.x,France,Article,Paris,1,Journal,2-s2.0-34848860775
Apetoh L.,,Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy,2007,Nature Medicine,1835,10.1038/nm1622,France;France;France,Article,Saint-Aubin;Villejuif;Paris,0,Journal,2-s2.0-34948820602
Peng G.,,Tumor-Infiltrating γδ T Cells Suppress T and Dendritic Cell Function via Mechanisms Controlled by a Unique Toll-like Receptor Signaling Pathway,2007,Immunity,257,10.1016/j.immuni.2007.05.020,United States;United States,Article,Houston;Houston,1,Journal,2-s2.0-34548024379
Mattarollo S.,,Chemotherapy and zoledronate sensitize solid tumour cells to Vγ9Vδ2 T cell cytotoxicity,2007,"Cancer Immunology, Immunotherapy",108,10.1007/s00262-007-0279-2,Australia;Australia,Article,Brisbane;Greenslopes,0,Journal,2-s2.0-34248219009
Villadangos J.,,Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo,2007,Nature Reviews Immunology,443,10.1038/nri2103,Australia,Review,Melbourne,0,Journal,2-s2.0-34250893815
Swann J.B.,,"Type I IFN contributes to NK cell homeostasis, activation, and antitumor function",2007,Journal of Immunology,178,10.4049/jimmunol.178.12.7540,Australia,Article,Melbourne,1,Journal,2-s2.0-34250203538
Lou Y.,,Plasmacytoid dendritic cells synergize with myeloid dendritic cells in the induction of antigen-specific antitumor immune responses,2007,Journal of Immunology,89,10.4049/jimmunol.178.3.1534,United States,Article,Houston,1,Journal,2-s2.0-33846529159
Thedrez A.,,Self/non-self discrimination by human γδ T cells: Simple solutions for a complex issue?,2007,Immunological Reviews,109,10.1111/j.1600-065X.2006.00468.x,France,Review,Nantes,0,Journal,2-s2.0-33846794698
Chien Y.,,Antigen recognition by γδ T cells,2007,Immunological Reviews,127,10.1111/j.1600-065X.2006.00470.x,United States,Review,Stanford,0,Journal,2-s2.0-33846813811
Apetoh L.,,The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy,2007,Immunological Reviews,347,10.1111/j.1600-065X.2007.00573.x,France;France;France,Review,Saint-Aubin;Villejuif;Paris,0,Journal,2-s2.0-35748942876
Obeid M.,,Calreticulin exposure dictates the immunogenicity of cancer cell death,2007,Nature Medicine,1627,10.1038/nm1523,France;France;France,Article,Saint-Aubin;Villejuif;Paris,0,Journal,2-s2.0-33846057130
Raghuraman G.,,IFN-β-mediated up-regulation of CD1d in bacteria-infected APCs,2006,Journal of Immunology,40,10.4049/jimmunol.177.11.7841,United States,Article,Chicago,1,Journal,2-s2.0-33751572483
Lin E.Y.,,Macrophages regulate the angiogenic switch in a mouse model of breast cancer,2006,Cancer Research,679,10.1158/0008-5472.CAN-06-1278,United States,Article,New York,1,Journal,2-s2.0-33845767868
Galon J.,,"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome",2006,Science,3527,10.1126/science.1129139,France;France;France,Article,Paris;Paris;Paris,0,Journal,2-s2.0-33749319703
Ivanov I.,,The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17<sup>+</sup> T Helper Cells,2006,Cell,3371,10.1016/j.cell.2006.07.035,United States,Article,New York,1,Journal,2-s2.0-33748588423
Ohta A.,,A2A adenosine receptor protects tumors from antitumor T cells,2006,Proceedings of the National Academy of Sciences of the United States of America,483,10.1073/pnas.0605251103,United States;United States,Article,Boston;Bethesda,1,Journal,2-s2.0-33748357735
Speiser D.,,A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: Spontaneous priming and efficient boosting by vaccination,2006,Journal of Immunology,60,10.4049/jimmunol.177.2.1338,Switzerland,Article,Lausanne,1,Journal,2-s2.0-33745855138
Jinushi M.,,Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity,2006,Proceedings of the National Academy of Sciences of the United States of America,126,10.1073/pnas.0603503103,,Article,,1,Journal,2-s2.0-33745125681
Robson S.,,The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance,2006,Purinergic Signalling,586,10.1007/s11302-006-9003-5,United States,Article,Boston,1,Journal,2-s2.0-33846436678
Hagemann T.,,Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype,2006,Journal of Immunology,279,10.4049/jimmunol.176.8.5023,United Kingdom;United Kingdom,Article,London;London,1,Journal,2-s2.0-33645760428
Chitu V.,,Colony-stimulating factor-1 in immunity and inflammation,2006,Current Opinion in Immunology,403,10.1016/j.coi.2005.11.006,United States,Review,New York,0,Journal,2-s2.0-30044448462
Jinushi M.,,Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas,2005,Journal of Hepatology,153,10.1016/j.jhep.2005.05.026,Japan,Article,Suita,0,Journal,2-s2.0-27744566433
Chen J.,,Tumor-associated macrophages: The double-edged sword in cancer progression,2005,Journal of Clinical Oncology,293,10.1200/JCO.2005.12.172,,Article,,0,Journal,2-s2.0-14644394928
Gardai S.,,Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte,2005,Cell,847,10.1016/j.cell.2005.08.032,United States;United States,Article,Denver;Denver,1,Journal,2-s2.0-26844468253
Tachibana T.,,Increased intratumor Vα24-positive natural killer T cells: A prognostic factor for primary colorectal carcinomas,2005,Clinical Cancer Research,158,10.1158/1078-0432.CCR-05-0877,Japan,Article,Kyoto,1,Journal,2-s2.0-27144471372
Corvaisier M.,,Vγ9Vδ2 T cell response to colon carcinoma cells,2005,Journal of Immunology,165,10.4049/jimmunol.175.8.5481,France,Article,Paris,1,Journal,2-s2.0-26844476689
Wang X.,,Autoantibody signatures in prostate cancer,2005,New England Journal of Medicine,490,10.1056/NEJMoa051931,United States,Article,Ann Arbor,0,Journal,2-s2.0-25144483466
Smyth M.J.,,NKG2D function protects the host from tumor initiation,2005,Journal of Experimental Medicine,234,10.1084/jem.20050994,Australia,Article,Melbourne,1,Journal,2-s2.0-24344479617
Zhang T.,,Chimeric NK-receptor-bearing T cells mediate antitumor immunotherapy,2005,Blood,99,10.1182/blood-2004-11-4365,United States,Article,Hanover,0,Journal,2-s2.0-23944488287
Parekh V.V.,,Glycolipid antigen induces long-term natural killer T cell anergy in mice,2005,Journal of Clinical Investigation,311,10.1172/JCI24762,United States,Article,Nashville,0,Journal,2-s2.0-24644433401
Gasser S.,,The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor,2005,Nature,899,10.1038/nature03884,United States,Article,Berkeley,0,Journal,2-s2.0-24144443517
Wei S.,,Plasmacytoid dendritic cells induce CD8<sup>+</sup> regulatory T cells in human ovarian carcinoma,2005,Cancer Research,300,10.1158/0008-5472.CAN-04-4043,United States,Article,New Orleans,1,Journal,2-s2.0-20444485236
Guiducci C.,,Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection,2005,Cancer Research,398,10.1158/0008-5472.CAN-04-4262,Italy,Article,Milan,1,Journal,2-s2.0-17144398046
Gorgoulis V.,,Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions,2005,Nature,1558,10.1038/nature03485,Greece,Article,Athens,0,Journal,2-s2.0-17244366865
Bartkova J.,,DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis,2005,Nature,2027,10.1038/nature03482,Denmark,Article,Copenhagen,0,Journal,2-s2.0-17244367849
Burdelya L.,,Stat3 activity in melanoma cells affects migration of immune effector cells and nitric oxide-mediated antitumor effects,2005,Journal of Immunology,110,10.4049/jimmunol.174.7.3925,United States;United States,Article,Cleveland;Tampa,1,Journal,2-s2.0-20144376844
Bjørge L.,,Ascitic complement system in ovarian cancer,2005,British Journal of Cancer,92,10.1038/sj.bjc.6602334,Norway;Norway;Norway;Finland,Article,Bergen;Bergen;Bergen;Helsinki,1,Journal,2-s2.0-16244406519
Ytting H.,,Serum mannan-binding lectin-associated serine protease 2 levels in colorectal cancer: Relation to recurrence and mortality,2005,Clinical Cancer Research,47,10.1158/1078-0432.CCR-04-1272,Denmark,Article,Hvidovre,1,Journal,2-s2.0-14644445180
Viey E.,,Phosphostim-activated γδ T cells kill autologous metastatic renal cell carcinoma,2005,Journal of Immunology,156,10.4049/jimmunol.174.3.1338,France;France,Article,Marseille;Villejuif,1,Journal,2-s2.0-12444255107
Liu Z.,,Ex vivo expanded human Vγ9Vδ2+ γδ-T cells mediate innate antitumor activity against human prostate cancer cells in vitro,2005,Journal of Urology,68,10.1097/01.ju.0000154355.45816.0b,United States,Article,Birmingham,0,Journal,2-s2.0-17144398106
Scotet E.,,Tumor recognition following Vγ9Vδ2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I,2005,Immunity,239,10.1016/j.immuni.2004.11.012,France,Article,Nantes,1,Journal,2-s2.0-19944432463
Yoshida H.,,Lethal anemia caused by interferon-β produced in mouse embryos carrying undigested DNA,2005,Nature Immunology,257,10.1038/ni1146,Japan,Article,Suita,0,Journal,2-s2.0-12344290452
Zhou D.,,Lysosomal glycosphingolipid recognition by NKT cells,2004,Science,791,10.1126/science.1103440,United States,Article,Chicago,0,Journal,2-s2.0-10044280324
Kabelitz D.,,Characterization of tumor reactivity of human Vγ9Vδ2 γδ T cells in vitro and in SCID mice in vivo,2004,Journal of Immunology,144,10.4049/jimmunol.173.11.6767,Germany;Germany,Article,Kiel;Kiel,1,Journal,2-s2.0-9144241718
Martín-Fontecha A.,,Induced recruitment of NK cells to lymph nodes provides IFN-γ for T<inf>H</inf>1 priming,2004,Nature Immunology,962,10.1038/ni1138,Switzerland,Article,Bellinzona,0,Journal,2-s2.0-13444262764
Wyckoff J.,,A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors,2004,Cancer Research,743,10.1158/0008-5472.CAN-04-1449,United States,Article,New York,1,Journal,2-s2.0-4944229701
Curiel T.J.,,Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival,2004,Nature Medicine,3537,10.1038/nm1093,United States,Article,New Orleans,0,Journal,2-s2.0-4644237613
Müller S.,,"Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function",2004,Journal of Internal Medicine,271,10.1111/j.1365-2796.2003.01296.x,Italy,Conference Paper,Milan,0,Journal,2-s2.0-1542345501
Bottino C.,,Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule,2003,Journal of Experimental Medicine,572,10.1084/jem.20030788,Italy,Article,Genova,1,Journal,2-s2.0-0042922822
Fujii S.,,Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein,2003,Journal of Experimental Medicine,568,10.1084/jem.20030324,United States,Article,New York,1,Journal,2-s2.0-0037787982
Wu D.Y.,,Cross-presentation of disialoganglioside GD3 to natural killer T cells,2003,Journal of Experimental Medicine,231,10.1084/jem.20030446,United States,Article,New York,1,Journal,2-s2.0-0038152830
Peterson A.,,Immunization with melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma,2003,Journal of Clinical Oncology,129,10.1200/JCO.2003.12.144,United States,Article,Chicago,0,Journal,2-s2.0-0037811736
Sohn J.H.,,Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells,2003,Nature Medicine,148,10.1038/nm814,United States,Article,Louisville,0,Journal,2-s2.0-0037324434
Gober H.,,Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells,2003,Journal of Experimental Medicine,597,10.1084/jem.20021500,Switzerland,Article,Basel,1,Journal,2-s2.0-0037455013
Zhang L.,,"Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer",2003,New England Journal of Medicine,2129,10.1056/NEJMoa020177,,Article,,0,Journal,2-s2.0-0037448353
Mocikat R.,,Natural killer cells activated by MHC class I<sup>Low</sup> targets prime dendritic cells to induce protective CD8 T cell responses,2003,Immunity,310,10.1016/S1074-7613(03)00264-4,Germany,Article,Neuherberg,1,Journal,2-s2.0-10744220243
Fishelson Z.,,Obstacles to cancer immunotherapy: Expression of membrane complement regulatory proteins (mCRPs) in tumors,2003,Molecular Immunology,292,10.1016/S0161-5890(03)00112-3,Israel,Conference Paper,Ramal Aviv,0,Journal,2-s2.0-0041563779
Groh V.,,Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation,2002,Nature,1138,10.1038/nature01112,United States,Article,Seattle,0,Journal,2-s2.0-0037126310
Crowe N.,,A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas,2002,Journal of Experimental Medicine,262,10.1084/jem.20020092,Australia,Article,Melbourne,1,Journal,2-s2.0-0036645278
Costello R.T.,,Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia,2002,Blood,336,10.1182/blood.V99.10.3661,Italy;France;Italy,Article,Genova;Marseille;Genoa,0,Journal,2-s2.0-0037093066
Valmori D.,,Circulating tumor-reactive CD8<sup>+</sup>T cells in melanoma patients contain a CD45RA<sup>+</sup>CCR7<sup>-</sup>effector subset exerting ex vivo tumor-specific cytolytic activity,2002,Cancer Research,93,,Switzerland,Article,Lausanne,0,Journal,2-s2.0-0037085937
Villegas F.,,Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer,2002,Lung Cancer,278,10.1016/S0169-5002(01)00292-6,Spain,Article,Madrid,0,Journal,2-s2.0-0036136050
Kelly J.,,Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection,2002,Nature Immunology,278,10.1038/ni746,Australia,Article,Melbourne,0,Journal,2-s2.0-0036143496
Bingle L.,,The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies,2002,Journal of Pathology,1352,10.1002/path.1027,United Kingdom,Review,Sheffield,0,Journal,2-s2.0-0036187615
Girardi M.,,Regulation of cutaneous malignancy by γδ T cells,2001,Science,719,10.1126/science.1063916,United Kingdom,Article,London,0,Journal,2-s2.0-0035914134
Masson D.,,Overexpression of the CD155 gene in human colorectal carcinoma,2001,Gut,160,10.1136/gut.49.2.236,France,Article,Nantes,1,Journal,2-s2.0-0034913210
Walport M.J.,,Advances in immunology: Complement (first of two parts),2001,New England Journal of Medicine,2119,10.1056/NEJM200104053441406,United Kingdom;United Kingdom,Review,London;London,0,Journal,2-s2.0-0035810399
Lin E.,,Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy,2001,Journal of Experimental Medicine,1152,10.1084/jem.193.6.727,United States,Article,New York,1,Journal,2-s2.0-0035911221
Smyth M.,,NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma,2001,International Immunology,303,10.1093/intimm/13.4.459,Australia,Article,Melbourne,1,Journal,2-s2.0-0035071525
Den Haan J.,,CD8<sup>+</sup> but not CD8<sup>-</sup> dendritic cells cross-prime cytotoxic T cells in vivo,2000,Journal of Experimental Medicine,934,10.1084/jem.192.12.1685,United States,Article,Seattle,1,Journal,2-s2.0-0034684659
Napirei M.,,Features of systemic lupus erythematosus in Dnase1-deficient mice,2000,Nature Genetics,615,10.1038/76032,Germany,Article,Bochum,0,Journal,2-s2.0-0034114882
Smyth M.J.,,Differential tumor surveillance by natural killer (NK) and NKT cells,2000,Journal of Experimental Medicine,624,10.1084/jem.191.4.661,Australia,Article,Melbourne,1,Journal,2-s2.0-0034695880
Ishigami S.,,Prognostic value of intratumoral natural killer cells in gastric carcinoma,2000,Cancer,369,10.1002/(SICI)1097-0142(20000201)88:3<577::AID-CNCR13>3.0.CO;2-V,Japan,Article,Kagoshima,1,Journal,2-s2.0-0034141680
Terabe M.,,NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway,2000,Nature Immunology,553,10.1038/82771,United States,Article,Bethesda,0,Journal,2-s2.0-0034569025
Anichini A.,,"An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions",1999,Journal of Experimental Medicine,161,10.1084/jem.190.5.651,Italy,Article,Milan,1,Journal,2-s2.0-0032844479
Jurianz K.,,Complement resistance of tumor cells: Basal and induced mechanisms,1999,Molecular Immunology,175,10.1016/S0161-5890(99)00115-7,Germany,Conference Paper,Heidelberg,0,Journal,2-s2.0-0033368042
Markiewicz M.,,The immune system as anti-tumor sentinel: Molecular requirements for an anti-tumor immune response,1999,Critical Reviews in Oncogenesis,39,,United States,Review,Chicago,0,Journal,2-s2.0-0032873001
Rosenberg S.,,Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma,1998,Nature Medicine,1649,10.1038/nm0398-321,United States,Article,Bethesda,0,Journal,2-s2.0-0031890206
Joyce S.,,Natural ligand of mouse CD1d1: Cellular glycosylphosphatidylinositol,1998,Science,358,10.1126/science.279.5356.1541,United States,Article,Hershey,0,Journal,2-s2.0-0032489652
Kawano T.,,CD1d-restricted and TCR-mediated activation of V(α)14 NKT cells by glycosylceramides,1997,Science,2025,10.1126/science.278.5343.1626,,Article,,0,Journal,2-s2.0-0030696696
Coca S.,,The prognostic significance of intratumoral natural killer cells in patients with colerectal carcinoma,1997,Cancer,430,10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P,Spain;Spain,Article,Madrid;Madrid,1,Journal,2-s2.0-0030902366
Gasque P.,,Complement activation on human neuroblastoma cell lines in vitro: Route of activation and expression of functional complement regulatory proteins,1996,Journal of Neuroimmunology,71,10.1016/0165-5728(96)00015-X,United Kingdom,Article,Cardiff,0,Journal,2-s2.0-0029896853
Lucas S.D.,,Tumor-specific deposition of immunoglobulin g and complement in papillary thyroid carcinoma,1996,Human Pathology,69,10.1016/S0046-8177(96)90346-9,Sweden;Sweden,Article,Uppsala;Uppsala,0,Journal,2-s2.0-0029829738
Boon T.,,From defined human tumor antigens to effective immunization?,1995,Immunology Today,111,10.1016/0167-5699(95)80149-9,Belgium,Article,Louvain-la-Neuve,0,Journal,2-s2.0-0029042676
Bendelac A.,,CD1 recognition by mouse NK1<sup>+</sup> T lymphocytes,1995,Science,808,10.1126/science.7538697,United States;United States,Article,Bethesda;Princeton,0,Journal,2-s2.0-0029029565
Lantz O.,,An invariant T cell receptor α Chain is used by a unique subset of major histocompatibility complex class I-specific CD4<sup>+</sup> and CD4-8- T cells in mice and humans,1994,Journal of Experimental Medicine,857,10.1084/jem.180.3.1097,United States;France,Article,Bethesda;Villejuif,1,Journal,2-s2.0-0028025074
Niculescu F.,,Persistent complement activation on tumor cells in breast cancer,1992,American Journal of Pathology,114,,United States;Romania,Article,Baltimore;Cluj Napoca,0,Journal,2-s2.0-0026780644
